thiazoles has been researched along with Right Ventricular Dysfunction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, R; Chen, X; McLean, BA; Oudit, GY; Patel, VB; Shah, S; Vanhaesebroeck, B; Wang, F; Zhabyeyev, P | 1 |
| Ageno, W; Brekelmans, MP; Büller, HR; Cohen, AT; Grosso, MA; Lin, M; Meyer, G; Raskob, G; Segers, A; Verhamme, P; Weitz, JI; Wells, PS; Winters, SM | 1 |
| Barco, S | 1 |
| Ageno, W; Beenen, LF; Brekelmans, MP; Brenner, B; Buller, HR; Chen, CZ; Cohen, AT; Grosso, MA; Meyer, G; Raskob, G; Segers, A; Vanassche, T; Verhamme, P; Weitz, JI; Wells, PS; Zhang, G | 1 |
| Feola, M; Gallamini, A; Mattei, D; Mordini, N; Orzan, F; Rapezzi, D | 1 |
| Dumitrescu, D; Erdmann, E; Gerhardt, F; Rosenkranz, S; Seck, C; ten Freyhaus, H | 1 |
2 trial(s) available for thiazoles and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
Topics: Adult; Aged; Anticoagulants; Comparative Effectiveness Research; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pulmonary Embolism; Pyridines; Recurrence; Risk Assessment; Secondary Prevention; Thiazoles; Venous Thromboembolism; Ventricular Dysfunction, Right; Warfarin | 2016 |
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
Topics: Adolescent; Adult; Aged; Anticoagulants; Double-Blind Method; Equivalence Trials as Topic; Europe; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Pulmonary Embolism; Pyridines; Recurrence; Survival Rate; Thiazoles; Venous Thromboembolism; Ventricular Dysfunction, Right; Warfarin; Young Adult | 2016 |
4 other study(ies) available for thiazoles and Right Ventricular Dysfunction
| Article | Year |
|---|---|
PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction.
Topics: Animals; Antibiotics, Antineoplastic; Atrophy; Class I Phosphatidylinositol 3-Kinases; Doxorubicin; Female; Heart; Mice; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphoinositide-3 Kinase Inhibitors; Thiazoles; Ventricular Dysfunction, Right; Ventricular Remodeling | 2019 |
Edoxaban for pulmonary embolism with right ventricular dysfunction.
Topics: Humans; Pulmonary Embolism; Pyridines; Thiazoles; Venous Thromboembolism; Ventricular Dysfunction, Right | 2016 |
Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.
Topics: Dasatinib; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Hypertension, Pulmonary; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pyrimidines; Thiazoles; Transplantation, Homologous; Ventricular Dysfunction, Right | 2009 |
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia.
Topics: Antineoplastic Agents; Blood Pressure; Dasatinib; Familial Primary Pulmonary Hypertension; Hemodynamics; Humans; Hypertension, Pulmonary; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pulmonary Medicine; Pyrimidines; Thiazoles; Treatment Outcome; Ventricular Dysfunction, Right | 2011 |